| Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus B Ho, PD Johann, Y Grabovska, MJ De Dieu Andrianteranagna, F Yao, ... Neuro-oncology 22 (5), 613-624, 2020 | 200 | 2020 |
| Efficacy of high-dose chemotherapy and three-dimensional conformal radiation for atypical teratoid/rhabdoid tumor: a report from the Children’s Oncology Group Trial ACNS0333 AT Reddy, DR Strother, AR Judkins, PC Burger, IF Pollack, MD Krailo, ... Journal of Clinical Oncology 38 (11), 1175-1185, 2020 | 161 | 2020 |
| The molecular landscape of ETMR at diagnosis and relapse S Lambo, SN Gröbner, T Rausch, SM Waszak, C Schmidt, A Gorthi, ... Nature 576 (7786), 274-280, 2019 | 133 | 2019 |
| Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 116 | 2018 |
| Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study BK Li, A Vasiljevic, C Dufour, F Yao, BLB Ho, M Lu, EI Hwang, ... Acta neuropathologica 139, 223-241, 2020 | 104 | 2020 |
| A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh, Y Du, M Lu, N Patel, ... Cancer cell 36 (1), 51-67. e7, 2019 | 90 | 2019 |
| Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases D Holdhof, PD Johann, M Spohn, M Bockmayr, S Safaei, P Joshi, ... Acta neuropathologica 141, 291-301, 2021 | 79 | 2021 |
| DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells J Chung, YE Maruvka, S Sudhaman, J Kelly, NJ Haradhvala, V Bianchi, ... Cancer discovery 11 (5), 1176-1191, 2021 | 73 | 2021 |
| Atypical teratoid rhabdoid tumour: from tumours to therapies EA Richardson, B Ho, A Huang Journal of Korean Neurosurgical Society 61 (3), 302-311, 2018 | 60 | 2018 |
| Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors LM Hoffman, EA Richardson, B Ho, A Margol, A Reddy, L Lafay-Cousin, ... Neuro-oncology 22 (7), 944-954, 2020 | 35 | 2020 |
| Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy PED Chung, DMA Gendoo, R Ghanbari-Azarnier, JC Liu, Z Jiang, J Tsui, ... Nature communications 11 (1), 1825, 2020 | 33 | 2020 |
| Molecular classification and management of rare pediatric embryonal brain tumors P Sin-Chan, BK Li, B Ho, A Fonseca, A Huang Current Oncology Reports 20, 1-11, 2018 | 30 | 2018 |
| Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study S Khan, P Solano-Paez, T Suwal, M Lu, S Al-Karmi, B Ho, I Mumal, ... The Lancet Child & Adolescent Health 5 (11), 800-813, 2021 | 23 | 2021 |
| Diagnostic classification of childhood cancer using multiscale transcriptomics F Comitani, JO Nash, S Cohen-Gogo, AI Chang, TT Wen, A Maheshwari, ... Nature medicine 29 (3), 656-666, 2023 | 22 | 2023 |
| Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board JA Rubens, C Erker, H Lindsay, B Ho, B Li, E Bouffet, A Cohen, ... Neuro-Oncology Advances 4 (1), vdac092, 2022 | 6 | 2022 |
| Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) K Howden, PJ McDonald, C Kazina, A Ong, B Ho, A Huang, BA Orr, ... Neuro-Oncology Advances 4 (1), vdac090, 2022 | 4 | 2022 |
| Reply to SA Upadhyaya AT Reddy, MD Krailo, AB Buxton, DR Strother, A Huang, T Zhou, ... Journal of Clinical Oncology 38 (28), 3353-3354, 2020 | 4 | 2020 |
| PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP BK Li, P Burger, AR Judkins, BLB Ho, G Kang, J Gossett, S Leary, ... Neuro-Oncology 22 (Supplement_3), iii429-iii429, 2020 | 2 | 2020 |
| ATRT-11. MOLECULAR SUBGROUPS OF ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): TOWARDS A CONSENSUS M Hasselblatt, PD Johann, B Ho, Y Grabovska, F Yao, F Bourdeaut, ... Neuro-Oncology 20 (Suppl 2), i29, 2018 | 2 | 2018 |
| Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways S Feng, SA Marhon, DJ Sokolowski, A D’Costa, F Soares, P Mehdipour, ... Nature communications 15 (1), 9321, 2024 | 1 | 2024 |
